Subject of the case
Operative part
Subject of the case
Re:
APPLICATION for annulment of the letter of 21 October 2010 (EMA/643425/2010) by which the European Medicines Agency (EMA) refused to repay to the applicant the sum of EUR 180 700 corresponding to the difference between, on the one hand, the sum the applicant paid to it in respect of fees for the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products and, on the other hand, the sum which the applicant maintains it should have paid.
Operative part
Operative part
1. The action is dismissed.
2. Octapharma Pharmazeutika Produktionsgesellschaft mbH is ordered to pay the costs.